The rate of gonorrhea cases across Europe rose by 31% in 2023 compared with 2022, and is up 321% since 2014.
Two studies in California found significant reductions in chlamydia and syphilis in the year after doxycycline post-exposure prophylaxis guidelines were released.
The partnership will evaluate the clinical need and address market barriers for diagnostic, therapeutic, and preventive interventions for gonorrhea in low-resource countries.
The number of STIs declined almost 2% from 2022 to 2023, a sign that the dramatic rise in STIs since 2011 might be leveling off.
The global health organization says the lack of rapid diagnostic tests results in undertreatment and overtreatment of gonorrhea in low-resource nations
Most of the infections have been acquired abroad, and transmission in England has been limited, but officials are worried about the potential for wider spread.
The proportion of cases showing resistance or decreased susceptibility to two different antimicrobials nearly doubled from 2020 to 2021.
The money will help Prompt Diagnostics LLC develop a portable PCR test that can detect the presence of ceftriaxone-resistant gonorrhea.
A surveillance study found a threefold increase in extensively drug-resistant gonorrhea isolates.
New surveillance data from Europe show a significant rise in azithromycin-resistant gonorrhea in 2022, along with the detection of 2 ceftriaxone-resistant samples.
